To legalize or not to legalize cannabis, that is the question!

  title={To legalize or not to legalize cannabis, that is the question!},
  author={Marta di Forti},
  journal={World Psychiatry},
World Psychiatry 19:2 June 2020 disastrous if, in due time, the cannabis legalization experiment simply repeated the histories of other commodified substances and their collateral public health impacts. In that same vein, cannabis legalization ought not to support a de facto re-colonization of vulnerable (e.g., indigenous) populations or communities by psychoactive commodities, yet rather protect free, culturally appropriate choice-making and governance. In these overall respects, Uruguay’s… Expand
1 Citations

Topics from this paper

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
This review focuses on the potential therapeutic effects of Cannabis sativa and cannabinoids, as well as the acute and chronic toxic effects of cannabis use on various body systems. Expand


Assessing the public health impacts of legalizing recreational cannabis use: the US experience
  • W. Hall, M. Lynskey
  • Medicine, Business
  • World psychiatry : official journal of the World Psychiatric Association
  • 2020
It appears to have increased the frequency of cannabis use among adults, but not so far among youth, and the impact of legalizing adult recreational use on cannabis price, availability, potency and use; and regulatory policies that may increase or limit adverse effects of legalization is reviewed. Expand
Cannabis use in young people: The risk for schizophrenia
Evidence from both epidemiological and animal studies indicates that cannabis use during adolescence carries particular risk in addiction, and further studies are warranted given the increase in the concentration of the main active ingredient in street preparations of cannabis and a decreasing age of first-time exposure to cannabis. Expand
Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.
The findings suggest that although marijuana legalization advanced social justice goals, the small post-RML increase in risk for CUD among respondents aged 12 to 17 years and increased frequent use and Cud among adults 26 years or older in this study are a potential public health concern. Expand
Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
This study provides prospective evidence suggesting higher potency cannabis, on average in the U.S., increases risk for onset of first cannabis use disorder symptom, and development of guidelines regarding cannabis potency is critical for reducing the costs associated with negative health outcomes. Expand
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
In the state of Washington, USA, the legal cannabis market is currently dominated by high-THC cannabis flower, and features growing expenditures on extracts, and there are small but significant quantity discounts. Expand
Substance Abuse and Mental Health Services Administration
Abstract The Substance Abuse and Mental Health Services Administration (SAMHSA) is a public agency within the U.S. Department of Health and Human Services. The agency’s goal is to provide informationExpand
Legalizing Cannabis
Drug Alcohol Depend 2019;195:186-92
  • 2019
and Mental Health Services Administration
  • National survey on drug use and health 2017-18. Rockville: US Substance Abuse and Mental Health Services Administration,
  • 2019